Αποτελέσματα Αναζήτησης
13 Μαρ 2024 · The 2022 MASCC guideline on cannabinoids for GI symptoms in adults with cancer suggests against use of cannabinoids in the following circumstances: treatment of nausea and vomiting unrelated to chemotherapy; first-line treatment in the prevention of CINV; and prevention of radiotherapy-induced nausea and vomiting. 40 The MASCC guideline ...
13 Μαρ 2024 · In 2024, ASCO published a guideline on the use of cannabis and cannabinoids by adults with cancer. 1 The guideline provides strategies for open, nonjudgmental communication and also discusses evidence regarding cannabis and cannabinoids as cancer-directed therapy and for managing cancer symptoms and treatment side effects.
Cannabis for Palliative Care. Cancer patients are accessing cannabis to alleviate various symptoms and improve their quality of life. Cannabis medication may reduce the devastating symptoms experienced by cancer patients, such as pain, emesis, anxiety, loss of appetite, and poor sleep quality [320].
11 Μαρ 2022 · Drugs that target the endocannabinoid system are of interest as pharmacological options to combat cancer and to improve the life quality of cancer patients. From this perspective, cannabinoid...
13 Μαρ 2024 · Cannabis and/or cannabinoids used as cancer-directed treatment may cause significant clinical (eg, fatigue, confusion, feeling high) and financial toxicities without good-quality evidence of clinical benefit.
20 Οκτ 2020 · Current evidence for use of medical cannabis and cannabinoids in cancer patients is weak. However, healthcare professionals are in an ideal role to monitor and educate patients using medical cannabis and cannabinoids.
4 Μαρ 2022 · Among the best studied phytocannabinoids, cannabidiol (CBD) is most promising for the treatment of cancer as it lacks the psychotomimetic properties of delta-9-tetrahydrocannabinol (THC). In vitro studies and animal experiments point to a concentration- (dose-)dependent anticancer effect.
